Advanced search    

Search: authors:"David B. Seder"

4 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Tracheostomy Practices in Neurocritical Care

provided by Patient-Centered Outcomes Research Institute (Grant No. CER-1602-34137) Conflict of interest David B. Seder is co-Principle Investigator of the SETPOINT2 Trial of early vs. delayed tracheostomy

Cefepime-induced neurotoxicity: a systematic review

Cefepime is a widely used antibiotic with neurotoxicity attributed to its ability to cross the blood–brain barrier and exhibit concentration-dependent ϒ-aminobutyric acid (GABA) antagonism. Neurotoxic symptoms include depressed consciousness, encephalopathy, aphasia, myoclonus, seizures, and coma. Data suggest that up to 15% of ICU patients treated with cefepime may experience...

Association of gender to outcome after out-of-hospital cardiac arrest – a report from the International Cardiac Arrest Registry

Niklas Nielsen 1 Karl B Kern Michael R Mooney Richard R Riker Sten Rubertsson David B Seder Pascal Stammet Kjetil Sunde Eldar Sreide Barbara T Unger Hans Friberg 0 1 0 Department of Anaesthesiology and

Piperacillin-Induced Immune Hemolytic Anemia in an Adult with Cystic Fibrosis

We report a case of drug-induced immune hemolytic anemia (DIIHA) in an adult female with cystic fibrosis (CF), complicating routine treatment of a pulmonary exacerbation with intravenous piperacillin-tazobactam. Workup revealed a positive direct antiglobulin test (DAT) due to red blood cell (RBC)-bound IgG and C3 and piperacillin antibodies detectable in the patient's serum. The...